MindMaze Therapeutics Holding SA SEC filings MMTZF
MindMaze Therapeutics Holding SA has 60 filings in SEC EDGAR's recent list, going back to Mar 30, 2021. Its latest annual report, Form 20-F, was filed on Apr 30, 2024 for the period ended Dec 31, 2023. The most recent current report (Form 6-K) was filed on Dec 16, 2024. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Dec 16, 2024 | Dec 16, 2024 |
| 6-K | Current report (foreign issuer) | Nov 12, 2024 | Nov 12, 2024 |
| 6-K | Current report (foreign issuer) | Nov 5, 2024 | Nov 5, 2024 |
| 6-K | Current report (foreign issuer) | Oct 28, 2024 | Oct 28, 2024 |
| 6-K | Current report (foreign issuer) | Oct 22, 2024 | Oct 22, 2024 |
| 6-K | Current report (foreign issuer) | Oct 9, 2024 | Oct 9, 2024 |
| 6-K | Current report (foreign issuer) | Oct 7, 2024 | Oct 7, 2024 |
| 6-K | Current report (foreign issuer) | Sep 23, 2024 | Sep 23, 2024 |
| 6-K | Current report (foreign issuer) | Sep 19, 2024 | Sep 19, 2024 |
| 6-K | Current report (foreign issuer) | Sep 4, 2024 | Sep 4, 2024 |
| 6-K | Current report (foreign issuer) | Aug 30, 2024 | Aug 30, 2024 |
| 6-K | Current report (foreign issuer) | Aug 6, 2024 | Aug 6, 2024 |
| 6-K | Current report (foreign issuer) | Jun 28, 2024 | Jun 28, 2024 |
| 6-K | Current report (foreign issuer) | Jun 3, 2024 | Jun 3, 2024 |
| 6-K | Current report (foreign issuer) | May 10, 2024 | May 10, 2024 |
| 6-K | Current report (foreign issuer) | Apr 3, 2024 | Apr 3, 2024 |
| 6-K | Current report (foreign issuer) | Mar 27, 2024 | Mar 27, 2024 |
| 6-K | Current report (foreign issuer) | Feb 28, 2024 | Feb 28, 2024 |
| 6-K | Current report (foreign issuer) | Dec 5, 2023 | Dec 5, 2023 |
| 6-K | Current report (foreign issuer) | Nov 22, 2023 | Nov 22, 2023 |
| 6-K | Current report (foreign issuer) | Oct 10, 2023 | Oct 10, 2023 |
| 6-K | Current report (foreign issuer) | Sep 15, 2023 | Sep 15, 2023 |
| 6-K | Current report (foreign issuer) | Aug 31, 2023 | Aug 31, 2023 |
| 6-K | Current report (foreign issuer) | Jun 23, 2023 | Jun 23, 2023 |
| 6-K | Current report (foreign issuer) | Jun 20, 2023 | Jun 20, 2023 |
| 6-K | Current report (foreign issuer) | Jun 1, 2023 | Jun 1, 2023 |
| 6-K | Current report (foreign issuer) | May 3, 2023 | May 3, 2023 |
| 6-K | Current report (foreign issuer) | Apr 17, 2023 | Apr 17, 2023 |
| 6-K | Current report (foreign issuer) | Apr 5, 2023 | Apr 5, 2023 |
| 6-K | Current report (foreign issuer) | Apr 4, 2023 | Apr 4, 2023 |
| 6-K | Current report (foreign issuer) | Feb 8, 2023 | Feb 8, 2023 |
| 6-K | Current report (foreign issuer) | Oct 14, 2022 | Oct 14, 2022 |
| 6-K | Current report (foreign issuer) | Sep 15, 2022 | Sep 15, 2022 |
| 6-K | Current report (foreign issuer) | Aug 4, 2022 | Aug 4, 2022 |
Showing 34 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MMTZF (OTC), RLFTY (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Switzerland
- Headquarters
- Ch-1202 Geneva
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1854078
- Former names
- Relief Therapeutics Holding SA (until Mar 27, 2025); Relief Therapeutics Holding AG (until Mar 30, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.